| Title |
|
|
|
Moving osimertinib to first-line : the right "strategy" in the chessboard of epidermal growth factor receptor-mutated non-small cell lung cancer?
|
|
| Author |
|
|
|
|
|
| Language |
|
|
|
English
|
|
| Source (journal) |
|
|
|
Journal of thoracic disease / Guangzhou hu xi ji bing yan jiu suo; Hu xi ji bing guo jia zhong dian shi yan shi. - Hong Kong, 2009, currens |
|
| Publication |
|
|
|
Shatin : Ame publ co, 2018
|
|
| ISSN |
|
|
|
2072-1439
|
|
| Volume/pages |
|
|
|
10:s:[9](2018), p. S1076-S1080
|
|
| ISI |
|
|
|
000431688000029
|
|
| Pubmed ID |
|
|
|
29849216
|
|
| Full text (Publisher's DOI) |
|
|
| |
|
| Full text (open access) |
|
|
| |
|